Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 24 June, 2024 – an important day in the history of some truly bizarre goings on. It was [more…]
The Ethical Investor: Aussies can now buy Bitcoin ETFs on the ASX, but how ‘ESG’ is Bitcoin really?
ASX launched the VanEck Bitcoin ETF, marking the first Bitcoin ETF for Aussies Is there a rationale for ethical investors to consider investing in this [more…]
ScoPo’s Powerplays: ASX health stocks rise as M&A activity heats up
Investors more bullish as ASX health stock rise in past five days along with broader markets Integral Diagnostics and Capitol ink merger agreement to create [more…]
Imricor starts global trial for US FDA approval
Imricor’s VISABL-AFL global trial starts with two procedures successfully undertaken at French hospital The NorthStar 3D Mapping system praised as a “game-changer” for cardiac ablation [more…]
Resources Top 4: Brazilian and Canadian REEs, Swedish lithium and more – it’s a small cap’s world after all
Enova Mining has some Brazilian REE results just in… (reporter’s hand to ear)… I’m getting word just now… they’re “impressive” Meanwhile, our correspondents in Sweden [more…]
ASX Small Caps Lunch Wrap: Whose AI turned the drive-thru into a bun fight this week?
Local markets opened slightly higher this morning, but managed to offload any hint of advancement within about 35 minutes of business getting underway on the [more…]
Break it Down: Imricor has its finger on the pulse
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Fraser Palamara discusses the successful start Imricor [more…]
Long Shortz with Terra Metals: Another big yes for first drilling at Dante
Stockhead’s Sarah Hughan sits down with Terra Metals (ASX:TM1) managing director and CEO Thomas Line to get the short end of the long story on the [more…]
Break it Down: PharmAust cashes up for the fight against MND
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Fraser Palamara dives into the mega $10 [more…]
PharmAust raises $10m as share price soars 100pc year to date
PharmAust raises $10 million via institutional placement to progress pivotal trial Share price has rallied in 2024 as data shows lead drug monepantel significantly improves [more…]
